tirzepatide for kidney disease Long-Term Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF It's important to study the

Data from a 2021 clinical trial published in the New England Journal of Medicine showed that tirzepatide led to patients losing more weight and experiencing a lesser degree of common side effects like nausea and diarrhea when compared to semaglutide, the active ingredient in Wegovy and Ozempic

So, uh, surgical, menopause, uh, chemical menopause, these are also confirmation enough we don't have to do lab testing, but if your doctor does do lab testing, if you caught my perimenopause episode, I will link to it in the show notes

Pulm Ther (2022) 8(3):32731

Its human data stop at GH/IGF-1 surrogate markers

Eric Topol (42:01): I share those, especially since we don't have a way to get people off if people could and maintain their weight or that

What Simple Trick Empties Your Bowels Immediately